Phaseline

Targets › VEGFC

VEGFC (Vascular endothelial growth factor C): drug programs, companies and trials

2 programs from 2 companies in 6 trials: 3 Phase 3, 1 Phase 2, 1 Phase 1, 1 Phase 4; Ophthalmology; next expected readout Mar 2027.

Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. (UniProt, P49767)

Open in Phaseline: the race on VEGFC, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Shanghai Eye Disease Prevention and Treatment CenterConbercept
Vascular endothelial growth factor A inhibitor; Vascular endothelial growth factor B inhibitor; Placenta growth factor inhibitor
VEGFA, VEGFB, PGF, VEGFCPhase 4Diabetic Macular Edema–
4D Molecular Therapeutics4D-150
AAV-based gene therapy delivering miRNA targeting VEGF-C and codon-optimized aflibercept s
VEGFA, VEGFC, VEGFR2Phase 3Macular Neovascularization Secondary to Age-Related Macular Degeneration; Neovascular Age-Related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Diabetic Macular Edema …Mar 2027

Conditions

Diabetic Macular Edema (2) Macular Neovascularization Secondary to Age-Related Macular Degeneration (1) Neovascular Age-Related Macular Degeneration (nAMD) (1) Diabetic Macular Edema (DME) (1) Neovascular (Wet) Age-Related Macular Degeneration (1)

Modalities

mixed (1), antibody (1)

Companies

4D Molecular Therapeutics (1) Shanghai Eye Disease Prevention and Treatment Center (1)

Related targets

VEGFA (2) VEGFR2 (1) VEGFB (1) PGF (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.